Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

<< Previous

Bullboard Posts

Next >>

Post by ENEMENEMYNEMOon Aug 30, 2021 9:50pm

252 Views

Post# 33786214

McCrappity sees his shadow

https://youtu.be/1N4Hyn3H1Dg

So at the 30 min mark or so he said dosing first patient will start any day ( I truly now believe he lives on Venus...reallllly long days)

Then he said his head is spinning at how fast things are moving. Then that he spoke to some Big Pharm and none were interested hmmm. Then later he said doing a large trial currently is impossible.

WHAT AN F'N PIECE OF SHITE HE IS....

<< Previous

Bullboard Posts

Next >>

This gambling tech stock might be the safest bet you’ll make this year